What do We Know about Cryptic Aspergillosis?
Microorganisms · 28.04.2024 · 12 (5) · 886
DOI: 10.3390/microorganisms12050886 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Microorganisms, online erschienen am 28.04.2024. Verfasst von Nicholas Geremia und 8 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Infectious Diseases, Department of Clinical Medicine, Ospedale Dell'Angelo, 30174 Venice, Italy. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cryptic Aspergillus species are increasingly recognized as pathogens involved in human disease. They are ubiquitarian fungi with high tenacity in their environment and can express various resistance mechanisms, often due to exposure to antifungal agents employed in agriculture and farming. The identification of such species is increasing thanks to molecular techniques, and a better description of this type of pathogen is granted. Nevertheless, the number of species and their importance in the clinical setting still need to be well studied. Furthermore, their cross-sectional involvement in animal disease, plants, and human activities requires a multidisciplinary approach involving experts from various fields. This comprehensive review aims to provide a sharp vision of the cryptic Aspergillus species, from the importance of correct identification to the better management of the infections caused by these pathogens. The review also accentuates the importance of the One Health approach for this kind of microorganism, given the interconnection between environmental exposure and aspergillosis, embracing transversely the multidisciplinary process for managing the cryptic Aspergillus species. The paper advocates the need for improving knowledge in this little-known species, given the burden of economic and health implications related to the diffusion of these bugs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Unit of Infectious Diseases, Department of Clinical Medicine, Ospedale Dell'Angelo, 30174 Venice, Italy.
- Unit of Infectious Diseases, Department of Clinical Medicine, Ospedale Civile "S.S. Giovanni e Paolo", 30122 Venice, Italy.
- Department of Molecular Medicine, University of Padua, 35121 Padua, Italy.
- Unit of Infectious Diseases, Department of Medicine, Surgery and Pharmacy, University of Sassari, 07100 Sassari, Italy.
- Biomedical Science Department, School in Biomedical Science, University of Sassari, 07100 Sassari, Italy.
- Department of Laboratory Medicine and Pathology, Institute of microbiology, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.
ORCID-Profile: Nicholas Geremia, Federico Giovagnorio, Agnese Colpani, Andrea De Vito, Giorgia Caruana, Giordano Madeddu
Zitieren
APA
Geremia, N., Giovagnorio, F., Colpani, A., De Vito, A., Caruana, G., Meloni, M. C., Madeddu, G., Panese, S., & Parisi, S. G. (2024). What do We Know about Cryptic Aspergillosis?. Microorganisms, 12(5), 886. https://doi.org/10.3390/microorganisms12050886
Vancouver
Geremia N, Giovagnorio F, Colpani A, De Vito A, Caruana G, Meloni MC, et al. What do We Know about Cryptic Aspergillosis?. Microorganisms. 2024;12(5):886. doi:10.3390/microorganisms12050886
BibTeX
@article{Geremia2024,
author = {Geremia, Nicholas and Giovagnorio, Federico and Colpani, Agnese and De Vito, Andrea and Caruana, Giorgia and Meloni, Maria Chiara and Madeddu, Giordano and Panese, Sandro and Parisi, Saverio Giuseppe},
title = {What do We Know about Cryptic Aspergillosis?},
journal = {Microorganisms},
year = {2024},
volume = {12},
number = {5},
pages = {886},
doi = {10.3390/microorganisms12050886}
}
EUVIMED